Donegal Group Inc. Q2 2024 – Net Income Up 110%

Donegal Group Inc. (NASDAQ: DGICA) and (NASDAQ: DGICB) have reported their financial results for the second quarter and first half of 2024. The company's net income for the second quarter of 2024 was $4.2 million, or 13 cents per diluted Class A share, compared to $2.0 million, or 6 cents per diluted Class A share in the second quarter of 2023. Net premiums earned increased by 8.3% to $234.3 million, while net premiums written increased by 9.1% to $247.2 million.

The combined ratio for the second quarter of 2024 was 103.0%, an improvement from 104.7% in the second quarter of 2023. The net income included after-tax net investment gains of $0.6 million, compared to $2.0 million in the same period last year.

The company's book value per share was $14.48 at June 30, 2024, compared to $14.68 in the previous year. The annualized return on average equity was 3.4%, compared to 1.6% in the second quarter of 2023.

In terms of net premiums earned, the company saw growth from both its commercial lines, which increased by 2.8%, and personal lines, which increased by 16.8% in the second quarter of 2024 compared to the same period in 2023.

Furthermore, the net premiums written for the second quarter of 2024 increased by 9.1% compared to the same period in 2023. This increase was primarily attributed to new business writings, strong premium retention, and a continuation of renewal premium increases in both commercial and personal lines.

The loss ratio for the second quarter of 2024 increased to 70.6%, compared to 69.9% for the second quarter of 2023. The expense ratio decreased to 31.9% for the second quarter of 2024, compared to 34.2% for the second quarter of 2023.

Additionally, the company's investment strategy led to a net investment income of $11.1 million for the second quarter of 2024, which was a 9.0% increase compared to the same period in 2023.

Today the company's shares have moved 0.2% to a price of $14.03. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS